Mario Gabelli's CVS Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 112,713 shares of CVS Health Corporation (CVS) worth $8.94 M, representing 0.09% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2022, adding 112,305 shares. Largest reduction occurred in Q4 2017, reducing 283,990 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -14,768 | Reduce 11.58% | 112,713 | $79.36 |
| Q3 2025 | -4,300 | Reduce 3.26% | 127,481 | $75.39 |
| Q2 2025 | -3,215 | Reduce 2.38% | 131,781 | $68.98 |
| Q1 2025 | -8,857 | Reduce 6.16% | 134,996 | $67.75 |
| Q4 2024 | -18,694 | Reduce 11.50% | 143,853 | $44.89 |
| Q3 2024 | -4,665 | Reduce 2.79% | 162,547 | $62.88 |
| Q2 2024 | -19,302 | Reduce 10.35% | 167,212 | $59.06 |
| Q1 2024 | -21,390 | Reduce 10.29% | 186,514 | $79.76 |
| Q4 2023 | -7,742 | Reduce 3.59% | 207,904 | $78.96 |
| Q3 2023 | -2,300 | Reduce 1.06% | 215,646 | $69.82 |
| Q2 2023 | -85,216 | Reduce 28.11% | 217,946 | $69.13 |
| Q1 2023 | -27,592 | Reduce 8.34% | 303,162 | $74.31 |
| Q4 2022 | -6,596 | Reduce 1.96% | 330,754 | $93.19 |
| Q3 2022 | -23,276 | Reduce 6.45% | 337,350 | $95.37 |
| Q2 2022 | +112,305 | Add 45.23% | 360,626 | $92.66 |
| Q1 2022 | -5,462 | Reduce 2.15% | 248,321 | $101.21 |
| Q4 2021 | -5,778 | Reduce 2.23% | 253,783 | $103.16 |
| Q3 2021 | -7,570 | Reduce 2.83% | 259,561 | $84.86 |
| Q2 2021 | -7,675 | Reduce 2.79% | 267,131 | $83.44 |
| Q1 2021 | -19,122 | Reduce 6.51% | 274,806 | $75.23 |
| Q4 2020 | -11,889 | Reduce 3.89% | 293,928 | $68.30 |
| Q3 2020 | -21,831 | Reduce 6.66% | 305,817 | $58.40 |
| Q2 2020 | -154,005 | Reduce 31.97% | 327,648 | $64.97 |
| Q1 2020 | +51,674 | Add 12.02% | 481,653 | $59.33 |
| Q4 2019 | +740 | Add 0.17% | 429,979 | $74.29 |
| Q3 2019 | -98,694 | Reduce 18.69% | 429,239 | $63.07 |
| Q2 2019 | -939 | Reduce 0.18% | 527,933 | $54.49 |
| Q1 2019 | -4,141 | Reduce 0.78% | 528,872 | $53.93 |
| Q4 2018 | -17,304 | Reduce 3.14% | 533,013 | $65.52 |
| Q3 2018 | -59,723 | Reduce 9.79% | 550,317 | $78.72 |
| Q2 2018 | -47,430 | Reduce 7.21% | 610,040 | $64.35 |
| Q1 2018 | -107,776 | Reduce 14.08% | 657,470 | $62.21 |
| Q4 2017 | -283,990 | Reduce 27.07% | 765,246 | $72.50 |
| Q3 2017 | -31,286 | Reduce 2.90% | 1.05 M | $81.32 |
| Q2 2017 | -12,265 | Reduce 1.12% | 1.08 M | $80.46 |
| Q1 2017 | +21,170 | Add 1.98% | 1.09 M | $78.50 |
| Q4 2016 | +6,160 | Add 0.58% | 1.07 M | $78.91 |
| Q3 2016 | -74,521 | Reduce 6.54% | 1.07 M | $88.99 |
| Q2 2016 | -48,922 | Reduce 4.11% | 1.14 M | $95.74 |
| Q1 2016 | +10,112 | Add 0.86% | 1.19 M | $103.73 |
| Q4 2015 | -36,805 | Reduce 3.03% | 1.18 M | $97.77 |
| Q3 2015 | -144,385 | Reduce 10.62% | 1.22 M | $96.48 |
| Q2 2015 | -78,185 | Reduce 5.44% | 1.36 M | $104.88 |
| Q1 2015 | -51,100 | Reduce 3.43% | 1.44 M | $103.21 |
| Q4 2014 | -38,747 | Reduce 2.54% | 1.49 M | $96.31 |
| Q3 2014 | -35,632 | Reduce 2.28% | 1.53 M | $79.59 |
| Q2 2014 | -5,039 | Reduce 0.32% | 1.56 M | $75.37 |
| Q1 2014 | -31,656 | Reduce 1.98% | 1.57 M | $74.86 |
| Q4 2013 | -3,205 | Reduce 0.20% | 1.6 M | $71.57 |
| Q3 2013 | -1,965 | Reduce 0.12% | 1.6 M | $56.75 |
| Q2 2013 | +1.61 M | Add 0.00% | 1.61 M | $57.18 |
Mario Gabelli's CVS Health Corporation Investment FAQs
Mario Gabelli first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 1,605,507 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held CVS Health Corporation (CVS) for 51 quarters since Q2 2013.
Mario Gabelli's largest addition to CVS Health Corporation (CVS) was in Q2 2013, adding 1,605,507 shares worth $91.8 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 112,713 shares of CVS Health Corporation (CVS), valued at approximately $8.94 M.
As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 0.09% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in CVS Health Corporation (CVS) was 1,605,507 shares, as reported at the end of Q2 2013.